Nanomaterials to Enhance the Effect of Ionizing Radiation
The unique physicochemical properties of nanoparticles have made them especially attractive for mediating enhanced antitumor activity with various energy sources, such as light, magnetic field, radiofrequency, microwave, and ionizing radiation. Enhancement of radioresponse with nanoparticles is attributed to increased drug delivery, synergist interaction with different modes of cell killing, and/or increased cellular exposure to ionizing radiation beams. This thematic series aims to cover a broad scope of current research on the interaction between nanoparticles and radiation, and provide an outlook for clinical translation of nanotechnology in radiotherapy, one of the pillars of anticancer therapies.
Edited by: Chun Li (MD Anderson Cancer Center) and Fred Currell (Queen’s University, Belfast)
Deadline for submissions: 31 August 2016
Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cancer Nanotechnology. The complete manuscript should be submitted through the Cancer Nanotechnology submission system. To ensure that you submit to the correct thematic series please select the appropriate thematic series in the drop-down menu upon submission. In addition, indicate within your cover letter that you wish your manuscript to be considered as part of the thematic series on Nanomaterials to Enhance the Effect of Ionizing Radiation. All submissions will undergo rigorous peer review and accepted articles will be published within the journal as a collection.
Submissions will also benefit from the usual advantages of open access publication:
- Rapid publication: Online submission, electronic peer review and production make the process of publishing your article simple and efficient.
- High visibility and international readership in your field: Open access publication ensures high visibility and maximum exposure for your work - anyone with online access can read your article
- No space constraints: Publishing online means unlimited space for figures, extensive data and video footage
Authors retain copyright, licensing the article under a Creative Commons license: articles can be freely redistributed and reused as long as the article is correctly attributed.
Sign up to article alerts to keep updated on articles published in Cancer Nanotechnology - including articles published in this thematic series!